News
British animal genetics company Genus on Wednesday said the U.S. Food and Drug Administration (FDA) approved its PRP gene ...
More than 20,000 jobs were eliminated, billions of dollars in scientific research has been threatened or paused, and a budget ...
GE HealthCare Technologies trimmed its full-year profit forecast on Wednesday, as it expects a hit from U.S. President Donald ...
Health and Human Services employees were told in March to remove nicknames from email systems and signatures to comply with ...
Zevaskyn is the first and only autologous cell-based gene therapy for recessive dystrophic epidermolysis bullosa ...
The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve ...
21hOpinion
MedPage Today on MSNA Conversation With FDA Commissioner Marty MakaryAmong other things, Makary breaks some news here by stating, for the first time, that there will be no significant ...
AI is a transformational force in healthcare, but without cybersecurity as its foundation, it becomes a high-stakes gamble.
A shocking report on mifepristone has finally shown a light on how the FDA is harming, and even killing, thousands of women.
Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...
The drug cytisinicline could help expand options for quitting smoking, and if approved by the FDA, would be the first new ...
Pink slips have followed the green light at Entrada Therapeutics. | Pink slips have followed the green light at Entrada ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results